Concepedia

Huizi Sha

HS

Statistics

Publications

22

Citations

1.3K

H-Index

18

Active since

2014

Affiliations

Nanjing Drum Tower Hospital(Current)

Nanjing University

Jiangsu Cancer Hospital

Nanjing Medical University

Nanjing University of Chinese Medicine

Huizi Sha is an author at Nanjing Drum Tower Hospital specializing in oncology, pharmacology, and drug delivery.

ORCID

Publications per year

2014–2024

22

Publications

22

CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients

Shu Su, Bian Hu, Jie Shao et al. · Scientific Reports · 2016 · 303 citations · Full text

, , +17

iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer

Naiqing Ding, Zhengyun Zou, Huizi Sha et al. · Nature Communications · 2019 · 127 citations · Full text

, , +17

Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric cancer therapy

Huizi Sha, Zhengyun Zou, Kai Xin et al. · Journal of Controlled Release · 2014 · 102 citations · Full text

, , +17

CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer

Shu Su, Zhengyun Zou, Fangjun Chen et al. · OncoImmunology · 2016 · 99 citations · Full text

, , +17

Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment

Zhen Zhang, Hanqing Qian, Jie Huang et al. · International Journal of Nanomedicine · 2018 · 94 citations · Full text

, , +17

1–5 of 22